The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination. The market growth is largely […]
Tag: Pharmaceuticals
APhA announces 2025 Immunization Award recipients
WASHINGTON, Feb. 20, 2025 /PRNewswire/ — The American Pharmacists Association (APhA) has selected seven recipients of its 2025 Immunization Champion Awards, recognizing individuals and organizations who have made extraordinary contributions toward improved vaccination rates within […]
Bantam Pharmaceutical Announces Activation of First Phase 1 Clinical Trial Site at MD Anderson Cancer Center
RESEARCH TRIANGLE PARK, N.C., Feb. 20, 2025 /PRNewswire/ — Bantam Pharmaceutical, a drug discovery and development company targeting selective modulation of mitochondrial dynamics in cancer, today announced the activation of its first clinical trial site […]
EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ — Sobi® and Apellis Pharmaceuticals today announced the European Medicines Agency (EMA) has validated an indication extension application for Aspaveli® (pegcetacoplan) for the treatment of C3 glomerulopathy (C3G) and primary immune […]
BioArctic’s global license agreement with Bristol Myers Squibb for PyroGlutamate-amyloid-beta antibody program effective after antitrust clearance and closing USA – English USA – English
STOCKHOLM, Feb. 20, 2025 /PRNewswire/ — BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that BioArctic and its partner Bristol Myers Squibb (NYSE: BMY) have received clearance from the U.S. Federal Trade Commission (FTC) […]